The Facts of Enbrel

Enbrel was the first TNF (tumor necrosis factor) inhibitor approved in 1998 for the treatment of rheumatoid arthritis. Enbrel is also referred to as an anti-TNF drug or TNF blocker. Enbrel is genetically engineered to be like the receptors in the body which bind to tumor necrosis factor (TNF-alpha).

Biologic response modifiers which bind TNF-alpha (currently there are three - Enbrel, Remicade, and Humira) help reduce inflammation and prevent joint damage. Many patients have had great success with Enbrel or drugs in the same class. Learn more about The Facts of Enbrel.

• TNF Blockers (Enbrel, Remicade, Humira) - Test Your Knowledge
• Enbrel, Remicade, and Humira: How Are They Similar and Different?
• Biologic Response Modifier: What is it?
• Should Arthritis Patients Fear the Side Effects of Enbrel, Remicade, and Humira?

_{Photo by webking (iStockphoto)}